http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013128570-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013128570-A |
| titleOfInvention | OLIGOSACCHARIDE COMPOSITION FOR TREATMENT OF ACUTE RESPIRATORY INFECTIONS |
| abstract | 1. A composition comprising at least one N-acetyl lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide, for preventing acute respiratory infections (ARI) and / or alleviating the symptoms of acute respiratory infections. The composition of claim 1, wherein the N-acetyl lactosamine is selected from the group consisting of lacto-N-tetraose and lacto-N-neotetraose. The composition according to claim 1, in which the sialylated oligosaccharide is selected from the group consisting of 3'-sialyllactose and 6'-sialyllactose, and preferably contains simultaneously 3'-sialyllactose and 6'-sialyllactose, the ratio between 3'-sialyllactose and 6'- sialyllactose preferably lies between 5: 1 and 1: 2.4. The composition of claim 1, wherein the fucosylated oligosaccharide is selected from the group consisting of 2'-fucosyllactose, 3-fucosyllactose, difucosyllactose, lacto-N-fucopentaose, which are lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto -N-fucopentaose III and lacto-N-fucopentaose V, lacto-N-diffucopentaose, fucosyllacto-N-hexaose, difucosyllacto-N-hexaose I, and diflucosyllacto-N-neogenxaose II, and preferably flucosylated oligosaccharose 2-FL) .5. A composition according to claim 1, which contains at least one probiotic bacterial strain, said probiotic bacterial strain being preferably Bifidobacteria and / or Lactobacilli. The composition according to claim 1, which contains at least one prebiotic. The composition according to claim 1, which contains at least one phage or a mixture of phages. The composition according to any one of claims 1 to 7, which is the initial infant formula, infant formula, mixture for growing infants� |
| priorityDate | 2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.